Medication info

Hiroza Tablet

Prescription medicationTablet경구Expired
Ingredient · strength
Losartan Potassium›50mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
삼천당제약(주)
Appearance
Yellow oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 200607805 · Notified 2006.07.26

This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of blood pressure control in patients with hypertension not adequately controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The usual dosage for adults is 1 tablet of Losartan Potassium 50 mg/Hydrochlorothiazide 12.5 mg once daily. A dosage exceeding Losartan Potassium 100 mg/Hydrochlorothiazide 25 mg per day is not recommended. 1. Start with the combination therapy of Losartan Potassium and Hydrochlorothiazide, and if blood pressure is not controlled after 3 weeks, the maximum is Losartan Potassium 100 mg/Hydrochlorothiazide 25 mg.
Child dose
There is no experience in using this medication in children and adolescents, so the losartan-hydrochlorothiazide combination should not be administered to them.

Ingredients

Manufacturer
삼천당제약(주)

Efficacy & effects

Improvement of blood pressure control in patients with hypertension not adequately controlled with monotherapy

  • Hypertension
View approved original text

This medication is used in patients with hypertension whose blood pressure is not adequately controlled with monotherapy.

How to take

Adult dose

The usual dosage for adults is 1 tablet of Losartan Potassium 50 mg/Hydrochlorothiazide 12.5 mg once daily. A dosage exceeding Losartan Potassium 100 mg/Hydrochlorothiazide 25 mg per day is not recommended. 1. Start with the combination therapy of Losartan Potassium and Hydrochlorothiazide, and if blood pressure is not controlled after 3 weeks, the maximum is Losartan Potassium 100 mg/Hydrochlorothiazide 25 mg.

Child dose

There is no experience in using this medication in children and adolescents, so the losartan-hydrochlorothiazide combination should not be administered to them.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially during the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. This medication should not be taken if there is a hypersensitivity to it, specific kidney diseases, liver diseases, electrolyte imbalances, or if pregnant. Patients with hypotension or impaired kidney function, elderly patients, and diabetic patients should use this medication cautiously and have their blood pressure, kidney function, and electrolyte status regularly monitored during treatment. This medication can affect blood potassium levels, so it should not be taken with potassium supplements or potassium-containing medications, and potential drug interactions may occur, so consultation with a doctor or pharmacist is recommended. Dizziness or drowsiness may occur during treatment, so caution is needed when driving or operating machinery. If symptoms of hypersensitivity such as skin reactions, difficulty breathing, or swelling of the face or lips occur, discontinue use immediately and seek medical attention. There is insufficient experience with this medication in children and adolescents, so it should not be administered to them. For storage, keep in a place out of reach of children and securely sealed in its original container.

Side effects and when to seek care immediately

Serious side effects

Urticaria, angioedema (swelling of the lips and eyelids and facial rash), skin peeling, hemolysis, chest pain, facial swelling, syncope, arrhythmia, cerebrovascular accident, hypotension, myocardial infarction, secondary atrioventricular block, thrombocytopenia, angioedema (laryngeal/pharyngeal swelling that may cause airway obstruction, swelling of the face/lips/pharynx/tongue), vasculitis, anaphylaxis, hepatitis, renal failure, acute respiratory distress syndrome (ARDS), renal failure.

Mild side effects

Abdominal pain, swelling, palpitations, back pain, dizziness, cough, sinusitis, upper respiratory tract infection, weakness/fatigue, diarrhea, nausea, headache, bronchitis, pharyngitis, chest pain, facial swelling, fever, orthostatic hypotension, syncope, angina, arrhythmia (atrial fibrillation, sinus bradycardia, tachycardia, ventricular tachycardia, ventricular fibrillation), cerebrovascular accident, hypotension, myocardial infarction, secondary atrioventricular block, anorexia, constipation, toothache, dry mouth, dyspepsia, flatulence, gastric mucosal inflammation, vomiting.

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that blocks light and kept at a temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the medication's effectiveness for a long time.

Appearance and packaging

Appearance

Yellow oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.